THE ROLE OF FENTANYL CITRATE DURING ADJUVANT RADIATION THERAPY FOR BONE METASTASES
Authors
Antonella Mazzonello – articles in this journal
Radiotherapy Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Leonardo La Paglia – articles in this journal
Radiotherapy Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Loredana Purpura – articles in this journal
Radiotherapy Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Manuela Federico – articles in this journal
Radiotherapy Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Alfredo Colombo – articles in this journal
Medical Oncology Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Tommaso Schiacchitano – articles in this journal
Medical Oncology Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Fabio De Nicola – articles in this journal
Medical Oncology Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Ivan Fazio – articles in this journal
Corresponding author
Email
Radiotherapy Unit, Casa di Cura Macchiarella, Palermo, Italy, Italy.
Published
12 January 2026
Section
Original Articles
Abstract
Metrics
Abstract
Fentanyl citrate administration a few minutes before adjuvant radiotherapy treatment for bone metastases helps the patient to maintain the correct position during treatment, thus ensuring the achievement of optimum therapeutic results. This article describes our experience with the use of this compound.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
Article statistics
Smart Citations (scite.ai)
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Submit your article
Read the guidelines for authors before you start your submission.
Make a Submission